- Pharmaceutical Executive: November 2024
- Volume 44
- Issue 11
AI’s Attention Span
Developments in the world of artificial intelligence continue to accelerate at a rapid pace. Our November issue of Pharmaceutical Executive explores a few of those that are starting to deliver measurable gains for the industry.
Our coverage here at Pharmaceutical Executive has been all over the rise of artificial intelligence (AI) in life sciences and healthcare for the last couple years or so. Our
Offering such value, we hope, is the slate of various tech and AI-focused content featured in this month’s issue. That includes our
“C-suite pharma executives must champion large-scale AI adoption at scale and build a clear roadmap for democratizing this technology enterprise-wide,” the authors write.
The article details, via a use case, AI’s ability to provide “decision intelligence” by aggregating massive and complex data points into “bite-size” insights. Info can then be extracted to help predict such value drivers as R&D costs, clinical trial enrollment timelines, and a program’s probability of success. Those are just a few examples. The authors note that the intention of these tools is to integrate across business functions—with the goal of breaking down silos and offering a “360-degree operational view.”
As far as measurable gains for industry so far, according to the authors, AI initiatives at Sanofi have translated to $300 million in savings by predicting and mitigating 80% of low inventory risks. Broadly, as well, they cite a PwC report that finds that pharma companies that adopt AI across their organizations have the potential to double their operating profits and gain an additional $254 billion in those profits globally by 2030.
AI developments until then will likely continue to be fast and furious. We look forward to sharing the ones that matter most with you. Thanks for reading.
Mike Hennessy Jr. is President and CEO of MJH Life Sciences
Articles in this issue
11 months ago
Pharmaceutical Executive: November 2024 Issue (PDF)11 months ago
Noam Solomon: Bringing the Human Story to AI11 months ago
The Leap Forward: Practical Gains for Pharma AI Use11 months ago
Navigating the Current Landscape for Pharma Leadersabout 1 year ago
Digital Protection: Q&A with Jeffrey BernsteinNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.